Historical source coverage

2026, page 2

1719 selected records with a cited source date in 2026, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2026 by record type

4 types

October 2026

160 records on this page

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06700538

PeptideScanner retained ClinicalTrials.gov record NCT06700538 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07850050

PeptideScanner retained ClinicalTrials.gov record NCT07850050 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Tirzepatide

Tirzepatide preserves hematopoietic stem and progenitor cycling while remodeling inflammatory monocytes in obese mice.

PubMed lists PMID 42922752 in bioRxiv : the preprint server for biology as Journal Article, Preprint, with publication-date metadata of 2026-09-04 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

Development of chondroitin sulfate‑stabilized PLGA microspheres of exenatide via polarity gradient extraction.

PubMed lists PMID 42709517 in Pharmaceutical development and technology as Journal Article, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Diagnostic accuracy of bilateral inferior petrosal sinus sampling using desmopressin or corticotropic- releasing hormone in ACTH-dependent Cushing's syndrome: A systematic review and meta-analysis.

PubMed lists PMID 35478451 in Reviews in endocrine & metabolic disorders as Journal Article, Meta-Analysis, Systematic Review, with publication-date metadata of 2022-04-28 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Carfilzomib

Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis.

PubMed lists PMID 35578151 in International journal of hematology as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2022-05-17 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Calcitonin salmon

Drugs@FDA application ANDA216996

The official Drugs@FDA dataset lists original submission 1 for ANDA 216996 with status AP dated 2026-10-29, and names calcitonin salmon among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06774079

PeptideScanner retained ClinicalTrials.gov record NCT06774079 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pegcetacoplan

Temporal, Phenotypic, and Treatment-Context Heterogeneity in Retinal Vasculitis Reporting with Pegcetacoplan: A United States Pharmacovigilance Study.

PubMed lists PMID 42930807 in Journal of personalized medicine as Journal Article, with publication-date metadata of 2026-10-16 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Zilucoplan

Zilucoplan as a rescue therapy in myasthenic crisis: a case description and summary of early report experiences.

PubMed lists PMID 42467314 in Acta neurologica Belgica as Letter, with publication-date metadata of 2026-07-17 (day precision). PeptideScanner associated the retained record with the identity slug zilucoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04466566

PeptideScanner retained ClinicalTrials.gov record NCT04466566 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07504172

PeptideScanner retained ClinicalTrials.gov record NCT07504172 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07768813

PeptideScanner retained ClinicalTrials.gov record NCT07768813 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07900438

PeptideScanner retained ClinicalTrials.gov record NCT07900438 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-28, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Octreotide

Mechanistic Basis of Octreotide Therapy in Neonatal Postoperative Chylothorax: A Translational Case Report.

PubMed lists PMID 42940741 in Children (Basel, Switzerland) as Case Reports, Journal Article, with publication-date metadata of 2026-10-16 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glucagon

Dysregulated glucagon signaling contributes to hypoglycemia after vertical sleeve gastrectomy in mice.

PubMed lists PMID 42270043 in Molecular metabolism as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-06-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT02262832

PeptideScanner retained ClinicalTrials.gov record NCT02262832 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Vasopressin

ClinicalTrials.gov record NCT04501861

PeptideScanner retained ClinicalTrials.gov record NCT04501861 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was vasopressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07221591

PeptideScanner retained ClinicalTrials.gov record NCT07221591 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07782359

PeptideScanner retained ClinicalTrials.gov record NCT07782359 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07855900

PeptideScanner retained ClinicalTrials.gov record NCT07855900 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-27, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Gallium Ga 68 dotatate

ClinicalTrials.gov record NCT03206060

PeptideScanner retained ClinicalTrials.gov record NCT03206060 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07825857

PeptideScanner retained ClinicalTrials.gov record NCT07825857 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07893457

PeptideScanner retained ClinicalTrials.gov record NCT07893457 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Oxytocin

Context-dependent oxytocin receptor signaling: from molecular architecture to transcript-level receptor engineering.

PubMed lists PMID 42903669 in Frontiers in neuroscience as Journal Article, Review, with publication-date metadata of 2026-10-06 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Palopegteriparatide

Palopegteriparatide: Parathyroid Hormone Analog for the Treatment of Chronic Hypoparathyroidism in Adults.

PubMed lists PMID 42924498 in The Annals of pharmacotherapy as Journal Article, Review, with publication-date metadata of 2026-10-23 (day precision). PeptideScanner associated the retained record with the identity slug palopegteriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

Salmon calcitonin prescribing for acute phantom limb pain after amputation.

PubMed lists PMID 42919113 in Anaesthesia as Journal Article, with publication-date metadata of 2026-10-22 (day precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Difelikefalin

ClinicalTrials.gov record NCT06593392

PeptideScanner retained ClinicalTrials.gov record NCT06593392 at 2026-11-15T21:56:33.343Z. Its registry update date was 2026-10-23, and PeptideScanner's reviewed identity mapping was difelikefalin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07891156

PeptideScanner retained ClinicalTrials.gov record NCT07891156 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-23, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pegcetacoplan

Distinct Pharmacodynamic Complement Biomarker Signatures Define Iptacopan and Pegcetacoplan Treatment in C3 Glomerulopathy.

PubMed lists PMID 42898424 in Kidney international reports as Journal Article, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Vasopressin

ClinicalTrials.gov record NCT07633600

PeptideScanner retained ClinicalTrials.gov record NCT07633600 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-22, and PeptideScanner's reviewed identity mapping was vasopressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07889453

PeptideScanner retained ClinicalTrials.gov record NCT07889453 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-10-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07889648

PeptideScanner retained ClinicalTrials.gov record NCT07889648 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-22, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Thymosin beta-4

ClinicalTrials.gov record NCT02974907

PeptideScanner retained ClinicalTrials.gov record NCT02974907 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-10-21, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT05247905

PeptideScanner retained ClinicalTrials.gov record NCT05247905 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Thymopentin

Thymopentin treatment of herpes simplex infections. An open, monitored, multicenter study.

PubMed lists PMID 2863860 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

Thymopentin in active rheumatoid arthritis. An open, monitored study in 16 patients.

PubMed lists PMID 3898297 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT07884201

PeptideScanner retained ClinicalTrials.gov record NCT07884201 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06977438

PeptideScanner retained ClinicalTrials.gov record NCT06977438 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07874828

PeptideScanner retained ClinicalTrials.gov record NCT07874828 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-20, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Epitalon

Epitalon and Epithalamin: A Narrative Review of Mechanistic, Preclinical, and Clinical Evidence.

PubMed lists PMID 42884164 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2026-10-08 (day precision). PeptideScanner associated the retained record with the identity slug epitalon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

GLP-1s and criminality: US trial will test whether semaglutide can fight crime.

PubMed lists PMID 42901618 in BMJ (Clinical research ed.) as Journal Article, with publication-date metadata of 2026-10-20 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

Growth hormone (GH) peaks versus areas under the curve in the diagnosis of adult GH deficiency: analysis of the variables provided by the GHRH + GHRP-6 test.

PubMed lists PMID 15638293 in Pituitary as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Hexarelin

Hepatic extraction of hexarelin, a new peptidic GH secretagogue, in the isolated perfused rat liver.

PubMed lists PMID 9279881 in Pharmaceutical research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1997-08 (month precision). PeptideScanner associated the retained record with the identity slug hexarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Triptorelin

A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma.

PubMed lists PMID 12092661 in International urology and nephrology as Clinical Trial, Clinical Trial, Phase II, Journal Article, with publication-date metadata of 2001 (year precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT06976619

PeptideScanner retained ClinicalTrials.gov record NCT06976619 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07879612

PeptideScanner retained ClinicalTrials.gov record NCT07879612 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07881770

PeptideScanner retained ClinicalTrials.gov record NCT07881770 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-10-19, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Teriparatide

Conservative Treatment with Adjunctive Use of Teriparatide for Periprosthetic Humeral Fractures after Reverse Total Shoulder Arthroplasty: A Report of 6 Cases.

PubMed lists PMID 42876896 in Clinics in orthopedic surgery as Journal Article, Case Reports, with publication-date metadata of 2026-09-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glucagon

Adrenal hormones in the maintenance of glucose homeostasis during prolonged fasting in male glucagon-deficient mice.

PubMed lists PMID 42886203 in Journal of diabetes investigation as Journal Article, with publication-date metadata of 2026-10-16 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Survodutide

Interpreting Survodutide Renoprotection in a Hyperfiltration Model.

PubMed lists PMID 42897119 in Diabetes, obesity & metabolism as Letter, with publication-date metadata of 2026-10-19 (day precision). PeptideScanner associated the retained record with the identity slug survodutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Epicardial Versus Circulating Adiponectin: An Unresolved Distinction in Liraglutide's Anti-Arrhythmic Mechanism.

PubMed lists PMID 42891862 in Cardiovascular drugs and therapy as Letter, with publication-date metadata of 2026-10-17 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT06192108

PeptideScanner retained ClinicalTrials.gov record NCT06192108 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Selank

A new property of the synthetic anxiolytic Selank and its derivatives.

PubMed lists PMID 15508574 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Selank

Antiviral properties of structural fragments of the peptide Selank.

PubMed lists PMID 20506839 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pegcetacoplan

Podocyte and tubular vacuolization in patients receiving pegcetacoplan.

PubMed lists PMID 42800616 in Kidney international as Case Reports, Journal Article, with publication-date metadata of 2026-09-26 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vasopressin

Management of Arginine Vasopressin Deficiency (Central Diabetes Insipidus) in Neonates and Infants.

PubMed lists PMID 40602377 in Hormone research in paediatrics as Journal Article, Review, with publication-date metadata of 2025-07-02 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Kisspeptin-10

Maternal Kisspeptin-10 Treatment Partially Rescues Fetal and Postnatal Cardiac Programming Disrupted by Maternal Hypothyroidism.

PubMed lists PMID 42726152 in Cardiovascular toxicology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-09-11 (day precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06715514

PeptideScanner retained ClinicalTrials.gov record NCT06715514 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07855133

PeptideScanner retained ClinicalTrials.gov record NCT07855133 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07868354

PeptideScanner retained ClinicalTrials.gov record NCT07868354 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Motixafortide

ClinicalTrials.gov record NCT06506461

PeptideScanner retained ClinicalTrials.gov record NCT06506461 at 2026-11-16T01:39:10.285Z. Its registry update date was 2026-10-15, and PeptideScanner's reviewed identity mapping was motixafortide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Palopegteriparatide

Discontinuation of palopegteriparatide in chronic hypoparathyroidism without rebound hypocalcemia.

PubMed lists PMID 42871663 in JCEM case reports as Case Reports, Journal Article, with publication-date metadata of 2026-10-13 (day precision). PeptideScanner associated the retained record with the identity slug palopegteriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07847515

PeptideScanner retained ClinicalTrials.gov record NCT07847515 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-10-15, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · CJC-1295

Detection of CJC-1295 in Equine Plasma by ELISA.

PubMed lists PMID 42876013 in Drug testing and analysis as Journal Article, with publication-date metadata of 2026-10-14 (day precision). PeptideScanner associated the retained record with the identity slug cjc-1295. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Markers of the maternal oxytocin system and mother-infant bonding during the first postpartum year.

PubMed lists PMID 42716459 in Progress in neurobiology as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

PubMed lists PMID 42874119 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.

PubMed lists PMID 42874120 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity. Reply.

PubMed lists PMID 42874121 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2026-10-15 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Patient and caregiver experiences with a patient-support program for setmelanotide treatment of patients with Bardet-Biedl syndrome.

PubMed lists PMID 40484968 in Orphanet journal of rare diseases as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-06-08 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04082520

PeptideScanner retained ClinicalTrials.gov record NCT04082520 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07790861

PeptideScanner retained ClinicalTrials.gov record NCT07790861 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Rusfertide

VERIFY: A Phase III Trial of Rusfertide Versus Placebo in Phlebotomy-Dependent Patients With Polycythemia Vera Receiving Standard-of-Care Therapy.

PubMed lists PMID 42868322 in Journal of clinical oncology : official journal of the American Society of Clinical Oncology as Journal Article, with publication-date metadata of 2026-10-13 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT06108362

PeptideScanner retained ClinicalTrials.gov record NCT06108362 at 2026-11-15T21:47:40.408Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · LL-37

LL-37-MRGPRX2-Mast Cell Signaling in Rosacea: Current Evidence and Directions for Human Studies.

PubMed lists PMID 42861262 in Clinical, cosmetic and investigational dermatology as Journal Article, Review, with publication-date metadata of 2026-10-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Daptomycin for enterococcal bloodstream infections and endocarditis: reconciling clinical evidence, susceptibility testing, and regulatory frameworks.

PubMed lists PMID 42869054 in The Lancet. Infectious diseases as Journal Article, Review, with publication-date metadata of 2026-10-13 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06191848

PeptideScanner retained ClinicalTrials.gov record NCT06191848 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06911203

PeptideScanner retained ClinicalTrials.gov record NCT06911203 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07064486

PeptideScanner retained ClinicalTrials.gov record NCT07064486 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07310563

PeptideScanner retained ClinicalTrials.gov record NCT07310563 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07547878

PeptideScanner retained ClinicalTrials.gov record NCT07547878 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07743983

PeptideScanner retained ClinicalTrials.gov record NCT07743983 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07871799

PeptideScanner retained ClinicalTrials.gov record NCT07871799 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Petrelintide

Petrelintide and the evolving role of amylin agonism in obesity.

PubMed lists PMID 42810353 in The lancet. Diabetes & endocrinology as Journal Article, with publication-date metadata of 2026-09-29 (day precision). PeptideScanner associated the retained record with the identity slug petrelintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.

PubMed lists PMID 11407654 in Journal of endocrinological investigation as Journal Article, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Use of Desmopressin in Spontaneous Nontraumatic Intracerebral Hemorrhage Among Patients Taking Antiplatelet Therapy: Systematic Review and Bayesian Meta-analysis.

PubMed lists PMID 42864513 in Neurocritical care as Journal Article, Review, with publication-date metadata of 2026-10-12 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Hexarelin

Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa.

PubMed lists PMID 9258804 in Journal of endocrinological investigation as Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1997-05 (month precision). PeptideScanner associated the retained record with the identity slug hexarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Etelcalcetide for Treating Secondary Hyperparathyroidism: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.

PubMed lists PMID 29691773 in PharmacoEconomics as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2018-11 (month precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Regression of uremic tumoral calcinosis following the switch from cinacalcet to etelcalcetide in a hemodialysis patient without severe hyperphosphatemia.

PubMed lists PMID 42853437 in CEN case reports as Journal Article, Case Reports, with publication-date metadata of 2026-10-09 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Enfuvirtide

Enfuvirtide.

PubMed lists PMID 14664654 in Drugs as Journal Article, Review, with publication-date metadata of 2003 (year precision). PeptideScanner associated the retained record with the identity slug enfuvirtide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

Secretin as a treatment for autism: a review of the evidence.

PubMed lists PMID 15628608 in Journal of autism and developmental disorders as Journal Article, Meta-Analysis, Review, with publication-date metadata of 2004-10 (month precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Selank

Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia.

PubMed lists PMID 18197389 in Neuroscience and behavioral physiology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-02 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cerebrolysin

Cerebrolysin: a review of its use in dementia.

PubMed lists PMID 19848437 in Drugs & aging as Journal Article, Review, with publication-date metadata of 2009 (year precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Selank

The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome.

PubMed lists PMID 25371249 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, with publication-date metadata of 2014-11-05 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Desmopressin therapy in children and adults: pharmacological considerations and clinical implications.

PubMed lists PMID 35199198 in European journal of clinical pharmacology as Journal Article, Review, with publication-date metadata of 2022-02-23 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

PubMed lists PMID 3898294 in Survey of immunologic research as Clinical Trial, Journal Article, with publication-date metadata of 1985 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

Thymopentin and splenopentin as immunomodulators. Current status.

PubMed lists PMID 9638477 in Immunologic research as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 1998 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Pasireotide: a review of its use in Cushing's disease.

PubMed lists PMID 23605695 in Drugs as Journal Article, Review, with publication-date metadata of 2013-05 (month precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Drug disposition model of radiolabeled etelcalcetide in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis.

PubMed lists PMID 28063122 in Journal of pharmacokinetics and pharmacodynamics as Journal Article, with publication-date metadata of 2017-01-06 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cerebrolysin

Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series.

PubMed lists PMID 33620612 in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology as Journal Article, Meta-Analysis, with publication-date metadata of 2021-02-23 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dalbavancin

Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin.

PubMed lists PMID 34931283 in Clinical pharmacokinetics as Journal Article, Review, with publication-date metadata of 2021-12-21 (day precision). PeptideScanner associated the retained record with the identity slug dalbavancin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Lutetium Lu 177 dotatate

Hematological toxicities with Lutathera® for neuroendocrine neoplasms: post-marketing surveillance data from the US-FDA.

PubMed lists PMID 38849643 in Endocrine as Letter, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug lutetium-lu-177-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Clinical Pharmacokinetics of Daptomycin.

PubMed lists PMID 33313994 in Clinical pharmacokinetics as Journal Article, Review, with publication-date metadata of 2020-12-14 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

The Antibiotic Peptide Daptomycin Functions by Reorganizing the Membrane.

PubMed lists PMID 33620544 in The Journal of membrane biology as Journal Article, Review, with publication-date metadata of 2021-02-23 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Degarelix

[Treatment of advanced hormone-sensitive prostate cancer using degarelix].

PubMed lists PMID 34907463 in Der Urologe. Ausg. A as Journal Article, Review, with publication-date metadata of 2021-12-14 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Eptifibatide

Evaluation of the Rational use of Eptifibatide among Patients with Acute Coronary Syndrome Referred to Shahid Chamran Heart Hospital.

PubMed lists PMID 42846822 in Journal of research in pharmacy practice as Journal Article, with publication-date metadata of 2026-02-24 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07215559

PeptideScanner retained ClinicalTrials.gov record NCT07215559 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-09, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Carfilzomib

Carfilzomib, pomalidomide, and dexamethasone for multiple myeloma after carfilzomib, lenalidomide, and dexamethasone.

PubMed lists PMID 41134506 in International journal of hematology as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2025-10-24 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Anaphylaxis to tirzepatide confirmed by positive skin prick testing.

PubMed lists PMID 42735799 in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology as Journal Article, with publication-date metadata of 2026-09-14 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Partially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.

PubMed lists PMID 42432542 in BMC ophthalmology as Journal Article, Case Reports, with publication-date metadata of 2026-07-10 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07153471

PeptideScanner retained ClinicalTrials.gov record NCT07153471 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07589608

PeptideScanner retained ClinicalTrials.gov record NCT07589608 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07613307

PeptideScanner retained ClinicalTrials.gov record NCT07613307 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07808060

PeptideScanner retained ClinicalTrials.gov record NCT07808060 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07866183

PeptideScanner retained ClinicalTrials.gov record NCT07866183 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

MAFB is essential for the maintenance of adult human α-cell identity and glucagon secretion.

PubMed lists PMID 42845437 in bioRxiv : the preprint server for biology as Journal Article, Preprint, with publication-date metadata of 2026-08-14 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Palopegteriparatide

Off-label palopegteriparatide for severe pediatric postsurgical hypocalcemia.

PubMed lists PMID 42789535 in European journal of endocrinology as Journal Article, Case Reports, with publication-date metadata of 2026-10-05 (day precision). PeptideScanner associated the retained record with the identity slug palopegteriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07099742

PeptideScanner retained ClinicalTrials.gov record NCT07099742 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07668388

PeptideScanner retained ClinicalTrials.gov record NCT07668388 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-07, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Semaglutide

Evoke (+) trials of semaglutide for early alzheimer's disease: Innovations, lessons, and implications.

PubMed lists PMID 42785112 in The journal of prevention of Alzheimer's disease as Journal Article, Review, with publication-date metadata of 2026-09-24 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT04430894

PeptideScanner retained ClinicalTrials.gov record NCT04430894 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-10-06, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07284979

PeptideScanner retained ClinicalTrials.gov record NCT07284979 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-06, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Tirzepatide

Evaluation of clinical relevance of weight nadirs and weight regain during 3 years of treatment with tirzepatide in participants with obesity or overweight and prediabetes.

PubMed lists PMID 42831032 in Obesity pillars as Journal Article, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

Role of epidermal growth factor and growth hormone-releasing peptide-6 in acceleration of renal tissue repair after kanamycin overdosing in rats.

PubMed lists PMID 25194405 in Iranian journal of kidney diseases as Journal Article, with publication-date metadata of 2014-09 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06058585

PeptideScanner retained ClinicalTrials.gov record NCT06058585 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-05, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06706284

PeptideScanner retained ClinicalTrials.gov record NCT06706284 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-05, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07858331

PeptideScanner retained ClinicalTrials.gov record NCT07858331 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-05, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Oxytocin

Oxytocin and RAGE signaling at the intersection of social neurodevelopment and inflammation.

PubMed lists PMID 42415063 in Journal of translational medicine as Journal Article, Review, with publication-date metadata of 2026-07-07 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

Early closure of cranial base synchondroses in infants with Vosoritide-treated achondroplasia.

PubMed lists PMID 42825290 in Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology as Journal Article, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT04925193

PeptideScanner retained ClinicalTrials.gov record NCT04925193 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06861439

PeptideScanner retained ClinicalTrials.gov record NCT06861439 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-02, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Semaglutide

Detection and Excretion Profiling of Semaglutide Use in Human Urine by UHPLC-HRMS for Anti-Doping Purpose.

PubMed lists PMID 42823892 in Drug testing and analysis as Journal Article, with publication-date metadata of 2026-10-02 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT06109311

PeptideScanner retained ClinicalTrials.gov record NCT06109311 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-01, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Palopegteriparatide

Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH forward trial.

PubMed lists PMID 41636590 in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2026-09-24 (day precision). PeptideScanner associated the retained record with the identity slug palopegteriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Trofinetide

Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide.

PubMed lists PMID 42377739 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-30 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT05254314

PeptideScanner retained ClinicalTrials.gov record NCT05254314 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-10-01, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

Describing pharmacists' perspectives on current practices and barriers to outpatient glucagon use in people with diabetes.

PubMed lists PMID 42822764 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2026-10-01 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

September 2026

40 records on this page

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT03596450

PeptideScanner retained ClinicalTrials.gov record NCT03596450 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-30, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06854614

PeptideScanner retained ClinicalTrials.gov record NCT06854614 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-30, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07564414

PeptideScanner retained ClinicalTrials.gov record NCT07564414 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-30, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07849348

PeptideScanner retained ClinicalTrials.gov record NCT07849348 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-30, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07850765

PeptideScanner retained ClinicalTrials.gov record NCT07850765 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-09-30, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Lanreotide

Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single-Arm Phase II Study.

PubMed lists PMID 42791653 in Cancer medicine as Journal Article, Clinical Trial, Phase II, with publication-date metadata of 2026-10 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT01559935

PeptideScanner retained ClinicalTrials.gov record NCT01559935 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT03971461

PeptideScanner retained ClinicalTrials.gov record NCT03971461 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Glepaglutide

ClinicalTrials.gov record NCT07197944

PeptideScanner retained ClinicalTrials.gov record NCT07197944 at 2026-11-16T01:46:56.290Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was glepaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07701083

PeptideScanner retained ClinicalTrials.gov record NCT07701083 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Cerebrolysin

ClinicalTrials.gov record NCT07846488

PeptideScanner retained ClinicalTrials.gov record NCT07846488 at 2026-11-16T17:33:14.861Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was cerebrolysin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Thymosin alpha-1

Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.

PubMed lists PMID 42797537 in Pharmaceuticals (Basel, Switzerland) as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-alpha-1. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06603571

PeptideScanner retained ClinicalTrials.gov record NCT06603571 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07527910

PeptideScanner retained ClinicalTrials.gov record NCT07527910 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07845578

PeptideScanner retained ClinicalTrials.gov record NCT07845578 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-29, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · BPC-157

BPC 157 in Rodent Ischemia-Reperfusion Injury: A Critical Review of Preclinical Evidence.

PubMed lists PMID 42794771 in International journal of molecular sciences as Journal Article, Review, with publication-date metadata of 2026-09-19 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teriparatide

Dendritic Mesoporous Silica-Modified Decellularized Bone Matrix Scaffold for Sustained Teriparatide Delivery in Bone Defect Repair: Characterization, Drug Release, and In Vitro Biological Performance.

PubMed lists PMID 42797243 in Pharmaceutics as Journal Article, with publication-date metadata of 2026-08-26 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHK-Cu

GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.

PubMed lists PMID 42797253 in Pharmaceutics as Journal Article, Review, with publication-date metadata of 2026-08-27 (day precision). PeptideScanner associated the retained record with the identity slug ghk-cu. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Tirzepatide among patients with psoriasis and obesity.

PubMed lists PMID 42810204 in Medicina clinica as Journal Article, with publication-date metadata of 2026-09-29 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Endometrial Preparation Strategies for Frozen Embryo Transfer in Women with Adenomyosis: A Systematic Review of Hormone Replacement Therapy, Gonadotropin-Releasing Hormone Agonist, and Oxytocin Antag…

PubMed lists PMID 42799216 in International journal of women's health as Journal Article, Review, with publication-date metadata of 2026-09-21 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07078838

PeptideScanner retained ClinicalTrials.gov record NCT07078838 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-28, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Octreotide

Octreotide in the management of chyle leaks after head and neck surgery: a systematic review of cohort studies.

PubMed lists PMID 42478204 in The Journal of laryngology and otology as Journal Article, Review, with publication-date metadata of 2026-07-21 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Carfilzomib

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis.

PubMed lists PMID 34647444 in Haematologica as Clinical Trial, Phase III, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-06-01 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Palopegteriparatide

Palopegteriparatide therapy for hypoparathyroidism: targeting the PTH receptor rouses the sleeping skeleton.

PubMed lists PMID 42139093 in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research as Journal Article, with publication-date metadata of 2026-09-24 (day precision). PeptideScanner associated the retained record with the identity slug palopegteriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Carfilzomib

Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.

PubMed lists PMID 41719502 in Blood advances as Journal Article, Clinical Trial, Phase II, Clinical Trial, Phase I, with publication-date metadata of 2026-05-12 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Gallium Ga 68 dotatate

Pulmonary Metastasis of Grade 1 Meningioma Mimicking a Carcinoid Tumor: A Case Report with FDG PET/CT, Ga-68 DOTATATE PET/CT, and Pathological Confirmation.

PubMed lists PMID 42787917 in World journal of nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Measurement of ionized calcium with a point-of-care ionometer during etelcalcetide therapy.

PubMed lists PMID 41307414 in Clinical nephrology as Journal Article, Observational Study, Clinical Trial, Phase IV, with publication-date metadata of 2025 (year precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Trofinetide

Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States.

PubMed lists PMID 42294489 in Journal of health economics and outcomes research as Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT05583708

PeptideScanner retained ClinicalTrials.gov record NCT05583708 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-09-25, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Aviptadil

Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage?

PubMed lists PMID 41368453 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Editorial, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vasopressin

A Scoping Review on Salivary Oxytocin and Vasopressin Measurement in the Dog.

PubMed lists PMID 40867749 in Animals : an open access journal from MDPI as Journal Article, Review, with publication-date metadata of 2025-08-18 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06738979

PeptideScanner retained ClinicalTrials.gov record NCT06738979 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-25, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT07035093

PeptideScanner retained ClinicalTrials.gov record NCT07035093 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-25, and PeptideScanner's reviewed identity mapping was retatrutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07842640

PeptideScanner retained ClinicalTrials.gov record NCT07842640 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-09-25, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pegcetacoplan

Pharmacokinetic/pharmacodynamic analysis of geographic atrophy lesion area in patients receiving pegcetacoplan treatment or sham.

PubMed lists PMID 39497616 in CPT: pharmacometrics & systems pharmacology as Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2024-11-05 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Desmopressin

Desmopressin for nocturnal enuresis in children.

PubMed lists PMID 40728007 in The Cochrane database of systematic reviews as Journal Article, Systematic Review, Meta-Analysis, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-29 (day precision). PeptideScanner associated the retained record with the identity slug desmopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→